FGF1 and diabetes mellitus: Because elevated hypothalamic Agrp and Npy mRNA levels are a characteristic finding in rodent models of diabetes (16), we wondered whether NPY/AgRP neuron inhibition might be a target for the antidiabetic action of FGF1 in the MBH.